Gene · 5981
Papers2,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS). | Mov Disord | 2024 | 38480525 | PubTator, text mining | PubMed |
| Structural polymorphism of the nucleic acids in pentanucleotide repeats associated with the neurological disorder CANVAS. | J Biol Chem | 2024 | 38447794 | PubTator, text mining | PubMed |
| Structure of the PCNA unloader Elg1-RFC. | Sci Adv | 2024 | 38427736 | PubTator, text mining | PubMed |
| Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures. | Nucleic Acids Res | 2024 | 38381906 | PubTator, text mining | PubMed |
| RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile. | J Neurol | 2024 | 38381176 | PubTator, text mining | PubMed |
| Leave-one-out-analysis (LOOA): web-based tool to predict influential proteins and interactions in aggregate-crosslinking proteomic data. | Bioinformation | 2024 | 38352912 | PubTator, text mining | PubMed |
| Comprehensive Analysis of a Japanese Pedigree with Biallelic ACAGG Expansions in RFC1 Manifesting Motor Neuronopathy with Painful Muscle Cramps. | Cerebellum | 2024 | 38324175 | PubTator, text mining | PubMed |
| The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. | Clin Rheumatol | 2024 | 38311638 | PubTator, text mining | PubMed |
| Cerebellar Ataxia With Neuropathy and Vestibular Areflexia Syndrome Due to Replication Factor C Subunit 1 Gene Repeat Expansion. | Clin Nucl Med | 2024 | 38306376 | PubTator, text mining | PubMed |
| RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci. | Genome Biol | 2024 | 38297326 | PubTator, text mining | PubMed |
| Cranial Nerve Thinning Distinguishes RFC1-Related Disorder from Other Late-Onset Ataxias. | Mov Disord Clin Pract | 2024 | 38291837 | PubTator, text mining | PubMed |
| Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia. | Clin Transl Med | 2024 | 38279833 | PubTator, text mining | PubMed |
| LUSTR: a new customizable tool for calling genome-wide germline and somatic short tandem repeat variants. | BMC Genomics | 2024 | 38279154 | PubTator, text mining | PubMed |
| Delayed low-dose methotrexate excretion in a rheumatoid arthritis patient: A case report and literature review. | Medicine (Baltimore) | 2024 | 38277521 | PubTator, text mining | PubMed |
| Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS. | Nucleic Acids Res | 2024 | 38266156 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| Exploring DNA Damage and Repair Mechanisms: A Review with Computational Insights. | BioTech (Basel) | 2024 | 38247733 | PubTator, text mining | PubMed |
| Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection. | PLoS Pathog | 2024 | 38232124 | PubTator, text mining | PubMed |
| Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis. | World J Surg Oncol | 2024 | 38212758 | PubTator, text mining | PubMed |
| Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease. | Brain | 2024 | 38193360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5981/papers?page=9